INSM Insmed Incorporated - Common Stock
$126,95
Prezzo · Ago 18, 2026
Fondamentali al Ago 6, 2026
Intervallo 52 sett.
$90–$213
30% of range
Rating Analisti
BUY
30 analysts
Prezzo Obiettivo
$200
+58% upside
P/E (TTM)
-20.0
ROE
-128.4%
Margine di Profitto Netto
-210.5%
INSM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$126.95
Capitalizzazione di Mercato
$27.49B
P/E (TTM)
-20.0
EPS (TTM)
$-6.42
Ricavi (TTM)
$606M
Rendimento div.
—
ROE
-128.4%
D/E Debito/Patrimonio
0.7
Intervallo 52 sett.
$90 – $213
INSM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$606M
2016-12-31
→
2025-12-31
EPS
$-6.42
2019-12-31
→
2025-12-31
Flusso di cassa libero
$-968M
2016-12-31
→
2025-12-31
Margini
-210.5%
2019-12-31
→
2019-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
INSM
Mediana dei peer
P/E (TTM)
-20.0
17.7
P/S (TTM)
45.3
6.8
P/B
37.2
6.4
EV / EBITDA
-21.3
—
Price / FCF (Prezzo / FCF)
-28.4
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
INSM
Mediana dei peer
Operating Margin (Margine Operativo)
-205.6%
—
Net Profit Margin (Margine di Profitto Netto)
-210.5%
20.3%
ROA
-59.5%
11.4%
ROE
-128.4%
16.8%
ROIC
-97.8%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
INSM
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
0.7
—
Current Ratio (Rapporto corrente)
3.8
3.4
Quick Ratio
3.4
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
INSM
Mediana dei peer
Revenue YoY (Ricavi YoY)
66.7%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
35.2%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
29.8%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
INSM
Mediana dei peer
INSM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
30 analisti
- Acquisto forte 9 30,0%
- Compra 20 66,7%
- Mantieni 1 3,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
22 analisti · 2026-08-18
Mediana
$197.50
← Sotto tutti i target
$126.95
Basso
$169.00
Alto
$243.00
Target mediano
$197.50
+55,6%
Target medio
$200.05
+57,6%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.02%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.06 | $-0.80 | 0.74% |
| 31 Marzo 2026 | $-0.76 | $-0.98 | 0.22% |
| 31 Dicembre 2025 | $-1.54 | $-1.32 | -0.22% |
| 30 Settembre 2025 | $-1.75 | $-1.37 | -0.38% |
| 30 Giugno 2025 | $-1.70 | $-1.32 | -0.38% |
| 31 Marzo 2025 | $-1.42 | $-1.36 | -0.06% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | · | |
| Cost of Revenue | $123M | $86M | $66M | $55M | $44M | $40M | $24M | $2M | $0 | $0 | · | · | |
| Gross Profit | · | · | · | · | · | · | $112M | $7M | $0 | · | · | · | |
| R&D Expense | $771M | $598M | $571M | $398M | $273M | $181M | $132M | $145M | $110M | $123M | $74M | $56M | |
| SG&A Expense | $701M | $461M | $345M | $266M | $234M | $204M | $211M | $168M | $79M | $51M | $43M | $31M | |
| Operating Expenses | $1.85B | $1.24B | $1.01B | $703M | $564M | $430M | $372M | $317M | $189M | $173M | $117M | $87M | |
| Operating Income | $-1.25B | $-878M | $-710M | $-457M | $-375M | $-265M | $-235M | $-307M | $-189M | $-173M | $-117M | $-87M | |
| Interest Expense | $84M | $85M | $82M | $26M | $40M | $30M | $28M | $25M | $6M | $3M | $3M | $2M | |
| Other Non-op | $-2M | $29.0K | $2M | $-6M | $-3M | $405.0K | $-531.0K | $602.0K | $300.0K | $119.0K | $-33.0K | $141.0K | |
| Pretax Income | $-1.27B | $-910M | $-747M | $-480M | $-436M | $-293M | $-254M | $-324M | $-193M | $-176M | $-120M | $-90M | |
| Income Tax | $5M | $4M | $3M | $1M | $-2M | $1M | $777.0K | $201.0K | $-272.0K | $98.0K | $-2M | $-10M | |
| Net Income | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| EPS (Basic) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| EPS (Diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| Shares (Basic) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| Shares (Diluted) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| EBITDA | $-1.25B | $-878M | $-704M | $-452M | $-366M | $-256M | $-230M | $-304M | $-186M | $-171M | $-116M | · |
Stato Patrimoniale 27
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $510M | $555M | $482M | $1.07B | $717M | $533M | $487M | $495M | $381M | $163M | $283M | $159M | |
| Short-term Investments | $920M | $879M | $298M | $74M | $0 | · | · | · | · | · | · | · | |
| Receivables | $141M | $52M | $41M | $30M | $24M | $17M | $19M | $6M | $0 | · | · | · | |
| Inventory | $132M | $99M | $83M | $70M | $67M | $50M | $28M | $7M | $0 | · | · | · | |
| Prepaid Expense | $91M | $37M | $24M | $25M | $29M | $24M | $20M | $11M | $8M | $6M | $5M | $5M | |
| Current Assets | $1.79B | $1.62B | $929M | $1.27B | $837M | $623M | $555M | $519M | $389M | $168M | $288M | $165M | |
| PP&E (Net) | $103M | $80M | $65M | $56M | $53M | $54M | $60M | $23M | $12M | $10M | $8M | $8M | |
| PP&E (Gross) | $164M | $130M | $110M | $96M | $90M | $82M | $79M | $37M | $23M | $18M | $13M | $11M | |
| Accum. Depreciation | $61M | $50M | $45M | $39M | $37M | $28M | $19M | $14M | $11M | $8M | $5M | $3M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $0 | · | · | · | · | · | · | |
| Intangibles | $98M | $59M | $64M | $69M | $74M | $49M | $54M | $59M | $58M | · | · | · | |
| Total Assets | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Accounts Payable | $80M | $73M | $65M | $50M | $36M | $43M | $13M | $18M | $15M | $10M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | $61M | $38M | $40M | $38M | $17M | $17M | $11M | $10M | |
| Current Liabilities | $469M | $298M | $226M | $190M | $135M | $119M | $85M | $80M | $45M | $28M | $22M | $20M | |
| Capital Leases | $12M | $9M | $11M | $15M | $21M | $21M | $29M | · | · | · | · | · | |
| Other Non-current Liabilities | $6M | $499.0K | $3M | $9M | $20M | $9M | $11M | $0 | $765.0K | $693.0K | $572.0K | $23.0K | |
| Total Liabilities | $1.53B | $1.74B | $1.66B | $1.57B | $833M | $520M | $481M | $396M | $101M | $83M | $45M | $45M | |
| Long-term Debt | $547M | $1.12B | $1.18B | $1.15B | $800M | $450M | $450M | $450M | $55M | $55M | $25M | $25M | |
| Total Debt | $541M | $1.10B | $1.16B | $1.13B | $567M | $356M | $336M | $317M | $56M | $55M | $25M | · | |
| Common Stock | $2M | $2M | $1M | $1M | $1M | $1M | $897.0K | $773.0K | $766.0K | $620.0K | $618.0K | $498.0K | |
| Paid-in Capital | $6.37B | $4.65B | $3.11B | $2.78B | $2.67B | $2.11B | $1.80B | $1.49B | $1.32B | $919M | $900M | $657M | |
| Retained Earnings | $-5.64B | $-4.36B | $-3.45B | $-2.70B | $-2.27B | $-1.83B | $-1.54B | $-1.28B | $-958M | $-765M | $-589M | $-471M | |
| AOCI | $1M | $-2M | $-745.0K | $756.0K | $968.0K | $193.0K | $-10.0K | $-9.0K | $-3.0K | $-65.0K | · | · | |
| Stockholders' Equity | $739M | $285M | $-332M | $88M | $410M | $276M | $262M | $208M | $361M | $154M | $312M | $186M | |
| Liabilities + Equity | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Shares Outstanding | 214,255,853 | 179,383,000 | 147,978,000 | 135,654,000 | 118,738,000 | 102,763,060 | 89,682,387 | 77,307,521 | 76,610,508 | 62,019,889 | 61,813,995 | 49,806,131 |
Flusso di cassa 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $6M | $5M | $9M | $9M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Stock-based Comp | $153M | $97M | $75M | $58M | $46M | $36M | $27M | $26M | $18M | $18M | $16M | $11M | |
| Deferred Tax | $-27.0K | $-29.0K | $-54.0K | $-231.0K | $-3M | $0 | $0 | $0 | $-417.0K | $0 | $0 | · | |
| Amort. of Intangibles | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $0 | $0 | · | · | |
| Other Non-cash | · | · | $133M | $18M | $20M | $29M | $-28M | $36M | $12M | $9M | $-89.0K | · | |
| Operating Cash Flow | $-935M | $-684M | $-536M | $-400M | $-363M | $-219M | $-251M | $-258M | $-160M | $-147M | $-101M | $-64M | |
| CapEx | $33M | $22M | $13M | $10M | $7M | $6M | $42M | $13M | $3M | $4M | $3M | $5M | |
| Investing Cash Flow | $-65M | $-583M | $-224M | $-35M | $-64M | $-7M | $-42M | $-15M | $-3M | $-4M | $-3M | · | |
| Stock Issued | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | $0 | $223M | $109M | |
| Net Stock Activity | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | · | $223M | · | |
| Financing Cash Flow | $954M | $1.34B | $168M | $793M | $613M | $271M | $285M | $387M | $381M | $31M | $228M | · | |
| Net Change in Cash | $-45M | $73M | $-592M | $357M | $184M | $45M | $-8M | $114M | $219M | $-120M | $124M | $45M | |
| Taxes Paid | $4M | $2M | $2M | $2M | $2M | $814.0K | $339.0K | $154.0K | $166.0K | $85.0K | $-3M | $9M | |
| Free Cash Flow | $-968M | $-706M | $-550M | $-410M | $-371M | $-226M | $-293M | $-271M | $-163M | $-151M | $-104M | · | |
| Levered FCF | $-1.05B | $-791M | $-632M | $-437M | $-411M | $-255M | $-321M | $-297M | $-169M | $-154M | $-107M | · |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 82.3% | · | · | · | · | · | |
| Operating Margin | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% | -172.4% | -3124.9% | · | · | · | · | |
| Net Margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% | -186.4% | -3297.2% | · | · | · | · | |
| Pretax Margin | -209.7% | -250.2% | -244.8% | -195.7% | -231.6% | -178.0% | -185.8% | -3295.1% | · | · | · | · | |
| EBITDA Margin | -205.6% | -241.5% | -230.7% | -184.2% | -194.2% | -155.8% | -168.6% | -3088.3% | · | · | · | · | |
| ROA | -59.5% | -54.5% | -50.2% | -33.2% | -42.6% | -38.2% | -37.8% | -60.8% | -55.0% | -59.3% | -40.2% | · | |
| ROE | -128.4% | -237.7% | 241.3% | -1660.7% | -95.0% | -92.9% | -89.9% | -129.8% | -74.7% | -75.6% | -47.5% | · | |
| ROIC | -97.8% | -63.5% | -86.5% | -37.8% | -38.2% | -42.1% | -39.5% | -58.6% | -45.3% | -82.9% | -34.3% | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 | 5.2 | 6.5 | 6.5 | 8.7 | 6.0 | 12.9 | · | |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 | 4.6 | 5.9 | 6.3 | 8.5 | 5.8 | 12.7 | · | |
| Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| LT Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| Interest Coverage | -14.9 | -10.3 | -8.7 | -17.3 | -9.3 | -9.0 | -8.5 | -12.1 | -31.9 | -49.6 | -40.7 | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.8 | 0.8 | 1.0 | 1.4 | 0.7 | · | · | · | · | |
| Receivables Turnover | 6.3 | 7.8 | 8.6 | 9.1 | 9.2 | 9.2 | 11.0 | 3.6 | · | · | · | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 66.7% | 19.2% | 24.4% | 30.2% | 14.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.2% | 24.5% | 22.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 29.8% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | $12M | |
| Net Income TTM | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| Market Cap | $37.29B | $12.38B | $4.59B | $2.71B | $3.23B | $3.42B | $2.14B | $1.01B | $2.39B | $821M | $1.12B | · | |
| Enterprise Value | $36.40B | $12.05B | $4.96B | $2.69B | $3.08B | $3.24B | $1.99B | $836M | $2.06B | $713M | $864M | · | |
| P/E | -27.1 | -12.4 | -5.8 | -5.1 | -7.0 | -11.1 | -7.9 | · | · | · | · | · | |
| P/S | 61.5 | 34.1 | 15.0 | 11.0 | 17.2 | 20.8 | 15.7 | 103.1 | · | · | · | · | |
| P/B | 50.5 | 43.4 | -13.8 | 30.8 | 7.9 | 12.4 | 8.2 | 4.9 | 6.6 | 5.3 | 3.6 | · | |
| P / Tangible Book | 73.8 | 136.7 | · | · | 16.1 | 15.1 | · | · | · | · | · | · | |
| P / Cash Flow | -39.9 | -18.1 | -8.6 | -6.8 | -8.9 | -15.6 | -8.5 | -3.9 | -15.0 | -5.6 | -11.1 | · | |
| P / FCF | -38.5 | -17.5 | -8.3 | -6.6 | -8.7 | -15.2 | -7.3 | -3.7 | -14.7 | -5.4 | -10.8 | · | |
| EV / EBITDA | -29.2 | -13.7 | -7.0 | -5.9 | -8.4 | -12.7 | -8.7 | -2.8 | -11.1 | -4.2 | -7.5 | · | |
| EV / FCF | -37.6 | -17.1 | -9.0 | -6.5 | -8.3 | -14.4 | -6.8 | -3.1 | -12.7 | -4.7 | -8.3 | · | |
| EV / Revenue | 60.0 | 33.1 | 16.3 | 11.0 | 16.4 | 19.7 | 14.6 | 85.0 | · | · | · | · | |
| Earnings Yield | -3.7% | -8.1% | -17.2% | -19.6% | -14.2% | -9.0% | -12.6% | · | · | · | · | · |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $425M | $306M | $264M | $142M | $107M | $93M | $104M | $93M | $90M | $76M | $84M | $79M | $77M | $65M | $59M | $68M | |
| Cost of Revenue | $67M | $47M | $44M | $29M | $28M | $21M | $26M | $21M | $21M | $17M | $18M | $17M | $17M | $14M | $13M | $13M | |
| R&D Expense | $210M | $209M | $255M | $186M | $177M | $153M | $180M | $151M | $147M | $121M | $137M | $109M | $197M | $128M | $125M | $100M | |
| SG&A Expense | $247M | $247M | $212M | $186M | $155M | $148M | $143M | $119M | $107M | $93M | $90M | $91M | $84M | $80M | $73M | $76M | |
| Operating Expenses | $427M | $459M | $584M | $508M | $420M | $341M | $335M | $307M | $379M | $221M | $262M | $227M | $313M | $213M | $211M | $195M | |
| Operating Income | $-2M | $-153M | $-320M | $-366M | $-313M | $-248M | $-230M | $-213M | $-289M | $-146M | $-178M | $-148M | $-236M | $-148M | $-151M | $-128M | |
| Interest Expense | · | · | · | · | $21M | $22M | $22M | $21M | $21M | $21M | $21M | $20M | $21M | $20M | $16M | $3M | |
| Other Non-op | $-531.0K | $-736.0K | $-2M | $-603.0K | $453.0K | $132.0K | $-445.0K | $2M | $-269.0K | $-1M | $2M | $285.0K | $-488.0K | $-111.0K | $1M | $-2M | |
| Pretax Income | $-11M | $-162M | $-327M | $-369M | $-320M | $-256M | $-234M | $-220M | $-300M | $-157M | $-185M | $-158M | $-244M | $-159M | $-160M | $-131M | |
| Income Tax | $2M | $1M | $2M | $1M | $1M | $912.0K | $1M | $1M | $838.0K | $589.0K | $998.0K | $544.0K | $530.0K | $483.0K | $125.0K | $372.0K | |
| Net Income | $-13M | $-164M | $-328M | $-370M | $-322M | $-257M | $-236M | $-221M | $-301M | $-157M | $-186M | $-159M | $-245M | $-160M | $-160M | $-131M | |
| EPS (Basic) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| EPS (Diluted) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| Shares (Basic) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| Shares (Diluted) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| EBITDA | $-2M | $-153M | · | $-366M | $-313M | $-248M | · | $-213M | $-289M | $-146M | · | $-148M | $-236M | $-148M | · | $-128M |
Stato Patrimoniale 26
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $582M | $510M | $335M | $1.28B | $403M | $555M | $461M | $1.25B | $596M | · | $487M | $613M | $969M | · | $415M | |
| Short-term Investments | $616M | $641M | $920M | $1.35B | $572M | $796M | $879M | $1.01B | $0 | $0 | · | $299M | $305M | $30M | · | $99M | |
| Receivables | $215M | $179M | $141M | $65M | $55M | $48M | $52M | $42M | $40M | $37M | · | $36M | $31M | $31M | · | $27M | |
| Inventory | $142M | $133M | $132M | $121M | $108M | $101M | $99M | $98M | $90M | $83M | · | $78M | $77M | $71M | · | $66M | |
| Prepaid Expense | $116M | $78M | $91M | $66M | $62M | $55M | $37M | $41M | $41M | $43M | · | $27M | $26M | $29M | · | $25M | |
| Current Assets | $1.63B | $1.61B | $1.79B | $1.93B | $2.08B | $1.40B | $1.62B | $1.65B | $1.42B | $759M | · | $927M | $1.05B | $1.13B | · | $632M | |
| PP&E (Net) | $107M | $103M | $103M | $90M | $90M | $88M | $80M | $75M | $73M | $69M | · | $65M | $62M | $60M | · | $54M | |
| PP&E (Gross) | $174M | $166M | $164M | $147M | $145M | $141M | $130M | $124M | $120M | $115M | · | $108M | $104M | $100M | · | $92M | |
| Accum. Depreciation | $67M | $64M | $61M | $57M | $55M | $52M | $50M | $49M | $47M | $46M | · | $43M | $42M | $41M | · | $38M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | · | $136M | $136M | $136M | · | $136M | |
| Intangibles | $93M | $96M | $98M | $85M | $56M | $57M | $59M | $60M | $61M | $62M | $64M | $65M | $66M | $67M | · | $70M | |
| Total Assets | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Accounts Payable | $75M | $73M | $80M | $80M | $74M | $58M | $73M | $65M | $51M | $44M | · | $65M | $56M | $57M | · | $12M | |
| Current Liabilities | $439M | $361M | $469M | $417M | $312M | $239M | $298M | $259M | $524M | $421M | · | $197M | $204M | $188M | · | $138M | |
| Capital Leases | $8M | $10M | $12M | $8M | $8M | $8M | $9M | $10M | $12M | $14M | · | $13M | $13M | $15M | · | $17M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $6M | $5M | $499.0K | $3M | $3M | $3M | · | $6M | $11M | $10M | · | $11M | |
| Total Liabilities | $1.35B | $1.37B | $1.53B | $1.42B | $1.23B | $1.70B | $1.74B | $1.57B | $1.77B | $1.62B | · | $1.61B | $1.59B | $1.56B | · | $1.02B | |
| Long-term Debt | $547M | $547M | $547M | $547M | $547M | $1.12B | · | $972M | $1.19B | $1.18B | · | $1.17B | $1.17B | $1.16B | · | $800M | |
| Total Debt | $544M | $542M | · | $540M | $539M | $1.11B | · | $955M | $1.17B | $1.16B | · | $1.15B | $1.14B | $1.13B | · | $785M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $6.57B | $6.50B | $6.37B | $6.25B | $6.18B | $4.71B | $4.65B | $4.61B | $3.94B | $3.14B | · | $2.97B | $2.95B | $2.81B | · | $2.51B | |
| Retained Earnings | $-5.81B | $-5.80B | $-5.64B | $-5.31B | $-4.94B | $-4.62B | $-4.36B | $-4.12B | $-3.90B | $-3.60B | · | $-3.26B | $-3.10B | $-2.86B | · | $-2.54B | |
| AOCI | $-3M | $4.0K | $1M | $2M | $2M | $-902.0K | $-2M | $547.0K | $-3M | $-2M | · | $-2M | $-1M | $1M | · | $-1M | |
| Stockholders' Equity | $757M | $705M | $739M | $946M | $1.25B | $99M | $285M | $483M | $39M | $-465M | $-332M | $-289M | $-156M | $-45M | $88M | $-30M | |
| Liabilities + Equity | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Shares Outstanding | 218,281,059 | 216,521,841 | 214,255,853 | 212,583,015 | 211,110,658 | 181,900,074 | 179,382,635 | 178,846,991 | 166,666,599 | 148,560,882 | 147,978,000 | 143,049,197 | 142,750,463 | 136,429,216 | 135,654,000 | 121,726,199 |
Flusso di cassa 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $46M | $39M | $31M | $43M | $39M | $27M | $26M | $23M | $21M | $20M | $20M | $18M | $16M | $15M | $16M | |
| Deferred Tax | $0 | $0 | $-27.0K | $0 | $0 | $0 | $-29.0K | $0 | $0 | $0 | $-54.0K | $0 | $0 | $0 | $-231.0K | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-89M | $-223M | $-248M | $-220M | $-206M | $-262M | $-196M | $-181M | $-123M | $-184M | $-131M | $-136M | $-123M | $-146M | $-103M | $-90M | |
| CapEx | $6M | $3M | $17M | $2M | $3M | $10M | $7M | $4M | $7M | $5M | $2M | $3M | $5M | $3M | $5M | $582.0K | |
| Investing Cash Flow | $25M | $266M | $389M | $-762M | $228M | $80M | $132M | $-1.00B | $-7M | $295M | $2M | $7M | $-274M | $42M | $20M | $49M | |
| Stock Issued | · | · | $0 | $-256.0K | · | · | $-12.0K | $371M | · | · | $114M | $0 | · | · | $259M | $33M | |
| Financing Cash Flow | $27M | $30M | $34M | $33M | $858M | $29M | $159M | $397M | $781M | $3M | $123M | $1M | $44M | $-399.0K | $743M | $37M | |
| Net Change in Cash | $-37M | $72M | $176M | $-950M | $881M | $-152M | $94M | $-785M | $651M | $113M | $-5M | $-126M | $-356M | $-105M | $659M | $-1M | |
| Taxes Paid | $696.0K | $3M | $111.0K | $1M | $677.0K | $2M | $248.0K | $689.0K | $354.0K | $1M | $75.0K | $518.0K | $358.0K | $1M | $91.0K | $432.0K | |
| Free Cash Flow | · | $-226M | · | · | · | $-272M | · | · | · | $-189M | · | · | · | $-150M | · | · | |
| Levered FCF | · | · | · | · | · | $-294M | · | · | · | $-210M | · | · | · | $-170M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| Net Margin | -3.1% | -53.5% | · | -259.9% | -299.5% | -276.4% | · | -236.0% | -332.8% | -208.1% | · | -201.0% | -317.0% | -245.0% | · | -193.6% | |
| Pretax Margin | -2.7% | -53.0% | · | -259.0% | -298.3% | -275.4% | · | -235.0% | -331.8% | -207.3% | · | -200.3% | -316.3% | -244.2% | · | -193.1% | |
| EBITDA Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| ROA | -0.58% | -8.4% | · | -16.8% | -15.0% | -17.3% | · | -13.1% | -18.5% | -11.7% | · | -13.7% | -19.6% | -12.0% | · | -11.4% | |
| ROE | -1.3% | -40.7% | · | -51.8% | -49.9% | 140.3% | · | -227.3% | 514.2% | 61.7% | · | 99.6% | 439.1% | -424.7% | · | -55.2% | |
| ROIC | -0.14% | -12.4% | · | -24.7% | -17.6% | -20.7% | · | -14.9% | -23.9% | -20.9% | · | -17.3% | -24.0% | -13.7% | · | -17.0% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.5 | · | 4.6 | 6.7 | 5.9 | · | 6.4 | 2.7 | 1.8 | · | 4.7 | 5.2 | 6.0 | · | 4.6 | |
| Quick Ratio | 3.1 | 3.9 | · | 4.2 | 6.1 | 5.2 | · | 5.8 | 2.5 | 1.5 | · | 4.2 | 4.6 | 5.5 | · | 3.9 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 30.2 | -2.5 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 24.4 | -2.0 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| Interest Coverage | · | · | · | · | -14.7 | -11.5 | · | -10.1 | -13.6 | -6.9 | · | -7.3 | -11.4 | -7.4 | · | -38.1 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 3.1 | 2.7 | · | 2.6 | 2.3 | 2.2 | · | 2.4 | 2.5 | 2.2 | · | 2.5 | 2.6 | 2.3 | · | 2.9 |
Valutazione (TTM) 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $981M | $649M | · | $436M | $384M | $352M | · | $338M | $322M | $297M | · | $289M | $275M | $251M | · | $233M | |
| Net Income TTM | $-869M | $-1.11B | · | $-1.17B | $-1.10B | $-935M | · | $-837M | $-861M | $-721M | · | $-695M | $-631M | $-481M | · | $-434M | |
| Market Cap | $23.27B | $35.41B | · | $30.61B | $21.25B | $13.88B | · | $13.06B | $11.17B | $4.03B | · | $3.61B | $3.01B | $2.33B | · | $2.62B | |
| Enterprise Value | $22.66B | $34.72B | · | $29.47B | $19.93B | $13.78B | · | $12.54B | $11.09B | $4.60B | · | $3.97B | $3.23B | $2.46B | · | $2.89B | |
| P/E | -25.0 | -29.0 | · | -23.5 | -15.9 | -13.4 | · | -13.6 | -11.4 | -5.3 | · | -4.9 | -4.4 | -4.4 | · | -5.9 | |
| P/S | 23.7 | 54.6 | · | 70.2 | 55.3 | 39.4 | · | 38.6 | 34.7 | 13.6 | · | 12.5 | 10.9 | 9.3 | · | 11.3 | |
| P/B | 30.7 | 50.2 | · | 32.4 | 17.0 | 139.9 | · | 27.0 | 287.7 | -8.7 | · | -12.5 | -19.3 | -52.1 | · | -87.5 | |
| P / Tangible Book | 44.1 | 74.8 | · | 42.2 | 20.1 | · | · | 45.4 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -159.0 | · | · | · | -52.9 | · | · | · | -21.9 | · | · | · | -15.9 | · | · | |
| P / FCF | · | -156.5 | · | · | · | -51.0 | · | · | · | -21.4 | · | · | · | -15.5 | · | · | |
| EV / EBITDA | -14635.9 | -226.5 | · | -80.5 | -63.7 | -55.5 | · | -58.8 | -38.4 | -31.6 | · | -26.9 | -13.7 | -16.6 | · | -22.7 | |
| EV / FCF | · | -153.5 | · | · | · | -50.6 | · | · | · | -24.4 | · | · | · | -16.4 | · | · | |
| EV / Revenue | 23.1 | 53.5 | · | 67.6 | 51.9 | 39.1 | · | 37.1 | 34.4 | 15.5 | · | 13.7 | 11.7 | 9.8 | · | 12.4 | |
| Earnings Yield | -4.0% | -3.4% | · | -4.3% | -6.3% | -7.5% | · | -7.4% | -8.8% | -18.9% | · | -20.4% | -22.9% | -22.6% | · | -17.0% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $606M | $364M | $305M | $245M | $188M |
| Margine Operativo % | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% |
| Utile netto | $-1.28B | $-914M | $-750M | $-482M | $-435M |
| EPS Diluito | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 |
| Rapporto corrente | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-968M | $-706M | $-550M | $-410M | $-371M |
Ultime notizie Notizie recenti che menzionano questa società
- Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
- Pressioni Competitive Spingono Truist a Ridurre l'Obiettivo su Insmed (INSM)
- Insmed CEO rivela che la popolazione di pazienti giapponesi supera il mercato statunitense per la malattia polmonare
- Artisan Small Cap Fund ha Venduto Insmed (INSM) in Base alla Valutazione
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 751 filer · $16.3B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 137 (+28 vs trimestre precedente) | 113 (+21 vs trimestre precedente) | 248 (-30 vs trimestre precedente) | 231 (+3 vs trimestre precedente) | +38.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $1.246.915.143 | 11.694.946 | 7,63% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.109.696.908 | 10.407.962 | 6,79% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.043.902.026 | 9.790.865 | 6,39% | Azioni |
| BAKER BROS. ADVISORS LP | $937.841.355 | 8.796.111 | 5,74% | Azioni |
| Capital International Investors | $878.338.960 | 8.238.124 | 5,37% | Azioni |
| Darwin Global Management, Ltd. | $673.600.013 | 6.431.163 | 4,12% | Azioni |
| STATE STREET CORP | $645.282.792 | 6.052.174 | 3,95% | Azioni |
| Artisan Partners Limited Partnership | $580.195.955 | 5.441.718 | 3,55% | Azioni |
| RTW INVESTMENTS, LP | $516.347.866 | 4.842.880 | 3,16% | Azioni |
| AMERIPRISE FINANCIAL INC | $483.856.150 | 4.538.102 | 2,96% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $389.229.811 | 3.661.786 | 2,38% | Azioni |
| NORGES BANK | $360.124.083 | 3.377.641 | 2,20% | Azioni |
| MAVERICK CAPITAL LTD | $229.314.244 | 2.150.762 | 1,40% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $218.358.293 | 2.048.005 | 1,34% | Azioni |
| Qube Research & Technologies Ltd | $179.370.451 | 1.682.334 | 1,10% | Azioni |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $173.743.795 | 1.629.561 | 1,06% | Azioni |
| Integral Health Asset Management, LLC | $170.592.000 | 1.600.000 | 1,04% | Azioni |
| CITADEL ADVISORS LLC | $160.586.566 | 1.506.158 | 0,98% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $149.433.474 | 1.401.552 | 0,91% | Azioni |
| Balyasny Asset Management L.P. | $141.423.967 | 1.326.430 | 0,87% | Azioni |
| Paradigm Biocapital Advisors LP | $141.375.668 | 1.325.977 | 0,86% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $132.445.710 | 1.242.222 | 0,81% | Azioni |
| Pictet Asset Management Holding SA | $129.804.038 | 1.220.353 | 0,79% | Azioni |
| D. E. Shaw & Co., Inc. | $120.259.044 | 1.127.922 | 0,74% | Azioni |
| Hood River Capital Management LLC | $112.683.586 | 1.056.871 | 0,69% | Azioni |
| Castle Hook Partners LP | $105.906.712 | 993.310 | 0,65% | Azioni |
| JENNISON ASSOCIATES LLC | $96.501.143 | 905.094 | 0,59% | Azioni |
| TimesSquare Capital Management, LLC | $95.626.169 | 584.798 | 0,58% | Azioni |
| Polar Capital Holdings Plc | $94.984.773 | 890.872 | 0,58% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $92.119.680 | 864.000 | 0,56% | Opzione Call |
| FIL Ltd | $91.289.537 | 856.214 | 0,56% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $91.280.154 | 856.126 | 0,56% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $90.627.000 | 850.000 | 0,55% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.788.663 | 795.242 | 0,52% | Azioni |
| GOLDMAN SACHS GROUP INC | $81.873.498 | 767.900 | 0,50% | Opzione Put |
| AMERICAN CENTURY COMPANIES INC | $81.002.980 | 759.735 | 0,50% | Azioni |
| Caption Management, LLC | $78.973.434 | 740.700 | 0,48% | Opzione Put |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $77.763.723 | 729.354 | 0,48% | Azioni |
| GOLDMAN SACHS GROUP INC | $77.305.085 | 725.052 | 0,47% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76.670.442 | 719.100 | 0,47% | Opzione Put |
| Clearbridge Investments, LLC | $76.331.581 | 715.922 | 0,47% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76.297.272 | 715.600 | 0,47% | Opzione Call |
| ALLIANCEBERNSTEIN L.P. | $75.676.402 | 462.796 | 0,46% | Azioni |
| Ensign Peak Advisors, Inc | $74.948.636 | 702.951 | 0,46% | Azioni |
| Affinity Asset Advisors, LLC | $69.303.000 | 650.000 | 0,42% | Azioni |
| TWO SIGMA ADVISERS, LP | $68.745.800 | 395.000 | 0,42% | Azioni |
| Caption Management, LLC | $67.170.600 | 630.000 | 0,41% | Opzione Call |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $67.152.581 | 629.831 | 0,41% | Azioni |
| Squarepoint Ops LLC | $65.727.392 | 616.464 | 0,40% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $65.302.719 | 612.596 | 0,40% | Azioni |
| Railway Pension Investments Ltd | $64.473.114 | 604.700 | 0,39% | Azioni |
| Swiss National Bank | $63.280.249 | 593.512 | 0,39% | Azioni |
| Artia Global Partners LP | $62.804.724 | 589.052 | 0,38% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $62.220.874 | 583.665 | 0,38% | Azioni |
| Davern Capital Partners, LP | $59.688.435 | 559.824 | 0,37% | Azioni |
| Candriam S.C.A. | $59.131.121 | 555.131 | 0,36% | Azioni |
| Point72 Asset Management, L.P. | $57.254.620 | 536.997 | 0,35% | Azioni |
| Long Focus Capital Management, LLC | $56.295.360 | 528.000 | 0,34% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49.576.321 | 303.182 | 0,30% | Azioni |
| BlackRock, Inc. | $49.204.384 | 461.493 | 0,30% | Azioni |
| Bridgewater Associates, LP | $48.553.895 | 455.392 | 0,30% | Azioni |
| JANE STREET GROUP, LLC | $48.160.254 | 451.700 | 0,29% | Opzione Call |
| WELLINGTON MANAGEMENT GROUP LLP | $47.494.625 | 445.457 | 0,29% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $46.668.960 | 437.713 | 0,29% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $44.365.435 | 416.108 | 0,27% | Azioni |
| Palo Alto Investors LP | $44.138.548 | 413.980 | 0,27% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $42.729.564 | 400.765 | 0,26% | Azioni |
| Eagle Health Investments LP | $40.955.941 | 384.130 | 0,25% | Azioni |
| Prosight Management, LP | $40.047.432 | 375.609 | 0,24% | Azioni |
| GATEWAY INVESTMENT ADVISERS LLC | $38.916.300 | 365.000 | 0,24% | Azioni |
| Rock Springs Capital Management LP | $38.612.433 | 362.150 | 0,24% | Azioni |
| CITADEL ADVISORS LLC | $38.084.664 | 357.200 | 0,23% | Opzione Call |
| NEUBERGER BERMAN GROUP LLC | $37.086.246 | 347.836 | 0,23% | Azioni |
| JANE STREET GROUP, LLC | $36.975.816 | 346.800 | 0,23% | Opzione Put |
| ENVESTNET ASSET MANAGEMENT INC | $35.930.149 | 336.997 | 0,22% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $34.817.934 | 326.561 | 0,21% | Azioni |
| BANK OF AMERICA CORP /DE/ | $33.116.173 | 310.600 | 0,20% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $33.084.186 | 310.300 | 0,20% | Opzione Call |
| VICTORY CAPITAL MANAGEMENT INC | $32.695.129 | 306.651 | 0,20% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $32.437.642 | 304.236 | 0,20% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $31.622.852 | 296.594 | 0,19% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30.876.512 | 289.594 | 0,19% | Azioni |
| Defilade Capital Management, L.P. | $30.049.568 | 281.838 | 0,18% | Azioni |
| SAMLYN CAPITAL, LLC | $29.812.765 | 279.617 | 0,18% | Azioni |
| CITADEL ADVISORS LLC | $29.181.894 | 273.700 | 0,18% | Opzione Put |
| RHUMBLINE ADVISERS | $29.076.813 | 272.715 | 0,18% | Azioni |
| First Turn Management, LLC | $28.131.794 | 263.851 | 0,17% | Azioni |
| Bank of New York Mellon Corp | $27.412.962 | 257.109 | 0,17% | Azioni |
| California Public Employees Retirement System | $26.692.317 | 250.350 | 0,16% | Azioni |
| Vestal Point Capital, LP | $26.655.000 | 250.000 | 0,16% | Azioni |
| Fiera Capital Corp | $26.535.159 | 248.876 | 0,16% | Azioni |
| TD Asset Management Inc | $25.608.205 | 240.182 | 0,16% | Azioni |
| Caption Management, LLC | $25.162.320 | 236.000 | 0,15% | Azioni |
| Trails Edge Capital Partners, LP | $24.557.891 | 230.331 | 0,15% | Azioni |
| ADAR1 Capital Management, LLC | $24.364.802 | 228.520 | 0,15% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23.363.000 | 219.123 | 0,14% | Azioni |
| Assenagon Asset Management S.A. | $23.271.947 | 218.270 | 0,14% | Azioni |
| DNB Asset Management AS | $22.737.675 | 213.259 | 0,14% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $22.675.515 | 212.676 | 0,14% | Azioni |
| Longaeva Partners L.P. | $21.454.716 | 201.226 | 0,13% | Azioni |
Insider aziendali 48 insider · 29 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 23 Luglio 2026 M | 259.058 | 0 | 67 | $-31.886.073 |
| Timothy Whitten | President & CEO | 01 Giugno 2012 P | 10.000 | 0 | 0 | $0 |
| Geoffrey Allan | President, CEO and Chairman | 31 Marzo 2009 M | 1.715.557 | 0 | 0 | $0 |
| Sara Bonstein | Chief Financial Officer | 03 Giugno 2026 S | 69.082 | 0 | 1 | $-245.857 |
| Paolo Tombesi | Chief Financial Officer | 03 Gennaio 2019 A | 10.669 | 0 | 0 | $0 |
| Andrew T Drechsler | Chief Financial Officer | 01 Marzo 2017 M | 15.000 | 0 | 0 | $0 |
| Kevin P Tully | Executive VP & CFO | 21 Dicembre 2011 A | 377.344 | 0 | 0 | $0 |
| Steve C Glover | President Follow-on Biologics | 31 Marzo 2009 M | 372.113 | 0 | 0 | $0 |
| Ronald D Gunn | Executive Vice President & COO | 08 Dicembre 2005 A | 40.074 | 0 | 0 | $0 |
| Samuele Butera | SVP, GM, Global Respiratory | 23 Giugno 2026 A | 7.342 | 0 | 0 | $0 |
| Michael Alexander Smith | Chief Legal Officer | 22 Giugno 2026 S | 37.648 | 0 | 2 | $-393.852 |
| Orlov S Nicole Schaeffer | Chief People Strategy Officer | 02 Gennaio 2026 M | 41.754 | 0 | 9 | $-26.423.350 |
| John Drayton Wise | Chief Commercial Officer | 23 Maggio 2022 A | 78.137 | 0 | 0 | $0 |
| John Soriano | Chief Compliance Officer | 07 Settembre 2021 M | 35.204 | 0 | 0 | $0 |
| Christine A Pellizzari | Chief Legal Officer | 15 Maggio 2021 F | 149.985 | 0 | 0 | $0 |
| John Goll | Chief Accounting Officer | 03 Gennaio 2020 A | 14.166 | 0 | 0 | $0 |
| Paul Streck | Chief Medical Officer | 08 Agosto 2018 A | 15.996 | 0 | 0 | $0 |
| Eugene Jeffrey Sullivan | Chief Med. & Scientific Ofc. | 17 Maggio 2017 A | — | 0 | 0 | $0 |
| Mark Quigley | Vice President, Quality | 12 Maggio 2015 M | 0 | 0 | 0 | $0 |
| Peggy Berry | Vice President, Regulatory | 26 Febbraio 2015 A | — | 0 | 0 | $0 |
| Matthew Pauls | Chief Commercial Officer | 02 Giugno 2014 A | — | 0 | 0 | $0 |
| Andrea Holtzman Drucker | SVP, Gen. Counsel & Corp Sec. | 03 Giugno 2013 M | 45.000 | 0 | 0 | $0 |
| Renu Gupta | EVP & Chief Medical Officer | 23 Maggio 2013 A | 19.507 | 0 | 0 | $0 |
| Nicholas A. Labella Jr. | Chief Scientific Officer | 21 Dicembre 2011 A | — | 0 | 0 | $0 |
| Nicholas Lee Gurreri | Senior VP, Commercial Ops | 31 Gennaio 2011 A | — | 0 | 0 | $0 |
| Doug Farrar | Vice President, ITP | 31 Marzo 2009 M | 292.055 | 0 | 0 | $0 |
| Michael Duncan | Principal Financial Officer | 08 Dicembre 2005 A | — | 0 | 0 | $0 |
| Philip J Young | Chief Business Officer and EVP | 08 Dicembre 2005 A | — | 0 | 0 | $0 |
| Thomas A Keuer | Sr VP, ITP (Subsidiary) | 08 Dicembre 2005 A | — | 0 | 0 | $0 |
| Melvin Sharoky MD | Direttore | 13 Maggio 2026 A | 246.081 | 0 | 3 | $-6.849.100 |
| David W J Mcgirr | Direttore | 09 Febbraio 2026 G | 53.400 | 0 | 0 | $0 |
| Clarissa Desjardins | Direttore | 11 Maggio 2022 A | 35.595 | 0 | 0 | $0 |
| Elizabeth M Anderson | Direttore | 11 Maggio 2022 A | 42.317 | 0 | 0 | $0 |
| Leo Lee | Direttore | 11 Maggio 2022 A | 53.265 | 0 | 0 | $0 |
| David R Brennan | Direttore | 11 Maggio 2022 A | 95.521 | 0 | 0 | $0 |
| Alfred Altomari | Direttore | 11 Maggio 2022 A | 43.141 | 0 | 0 | $0 |
| Steinar J Engelsen | Direttore | 01 Novembre 2021 P | 320.802 | 0 | 0 | $0 |
| Donald J Hayden JR | Direttore | 09 Aprile 2019 M | 62.197 | 0 | 0 | $0 |
| Myrtle S Potter | Direttore | 15 Maggio 2018 A | 25.510 | 0 | 0 | $0 |
| Randall W Whitcomb | Direttore | 10 Marzo 2015 M | 69.188 | 0 | 0 | $0 |
| Richard S Kollender | Direttore | 31 Ottobre 2013 M | 24.598 | 0 | 0 | $0 |
| Dennis M Lanfear | Direttore | 09 Giugno 2010 A | 168.404 | 0 | 0 | $0 |
| Graham K Crooke | Direttore | 09 Giugno 2010 A | 228.404 | 0 | 0 | $0 |
| Kenneth G Condon | Direttore | 09 Giugno 2010 A | 168.504 | 0 | 0 | $0 |
| FMR LLC | Proprietario del 10% | 22 Luglio 2013 S | 2.221 | 0 | 0 | $0 |
| Roger Adsett | — | 10 Agosto 2026 M | 98.744 | 0 | 2 | $-32.207.190 |
| Martina Flammer M.D. | — | 06 Agosto 2026 M | 60.486 | 0 | 5 | $-5.110.195 |
| Carol Schafer | — | 13 Maggio 2026 A | 66.622 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 121 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 3,71% | 7.509 NS | 30 Aprile 2026 | N-PORT |
| IBB · iShares Trust | 2,19% | 1.576.476 SH | 08 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,94% | 11.797 SH | 08 Agosto 2026 | Giornaliero |
| FMED · Fidelity Covington Trust | 1,79% | 6.875 NS | 31 Maggio 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,70% | 15.835 NS | 31 Maggio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,44% | 92.576 NS | 30 Aprile 2026 | N-PORT |
| BIB · ProShares Trust | 1,16% | 7.968 NS | 31 Maggio 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,11% | 2.081 NS | 31 Maggio 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,10% | 4.801 NS | 30 Aprile 2026 | N-PORT |
| SPIT · RBB Fund, Inc. | 1,06% | 2.228 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,92% | 34.830 NS | 30 Aprile 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,90% | 80.500 NS | 30 Aprile 2026 | N-PORT |
| IWP · iShares Trust | 0,81% | 1.239.854 SH | 08 Agosto 2026 | Giornaliero |
| HRTS · Tema ETF Trust | 0,71% | 3.449 NS | 31 Maggio 2026 | N-PORT |
| LFSC · RBB Fund, Inc. | 0,62% | 6.050 NS | 31 Maggio 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 35.661 NS | 30 Aprile 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,50% | 40.138 NS | 30 Aprile 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,47% | 98.313 NS | 30 Aprile 2026 | N-PORT |
| IYH · iShares Trust | 0,46% | 128.330 SH | 08 Agosto 2026 | Giornaliero |
| FFSM · FIDELITY COVINGTON TRUST | 0,40% | 37.505 NS | 30 Aprile 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,39% | 36.063 NS | 30 Aprile 2026 | N-PORT |
| SMLF · iShares Trust | 0,39% | 123.385 SH | 08 Agosto 2026 | Giornaliero |
| IMCG · iShares Trust | 0,38% | 116.453 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,33% | 632.581 SH | 08 Agosto 2026 | Giornaliero |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 1.435.651 SH | 08 Agosto 2026 | Giornaliero |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 695 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,26% | 2.487.127 SH | 08 Agosto 2026 | Giornaliero |
| VOT · VANGUARD INDEX FUNDS | 0,25% | 830.249 SH | 08 Agosto 2026 | Giornaliero |
| FDG · AMERICAN CENTURY ETF TRUST | 0,24% | 9.338 NS | 31 Maggio 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 7.501 SH | 08 Agosto 2026 | Giornaliero |
| FFLG · FIDELITY COVINGTON TRUST | 0,22% | 9.640 NS | 30 Aprile 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,22% | 31.591 SH | 08 Agosto 2026 | Giornaliero |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,21% | 22.539 NS | 30 Aprile 2026 | N-PORT |
| ESLV · Strategy Shares | 0,20% | 176 NS | 30 Aprile 2026 | N-PORT |
| IWR · iShares Trust | 0,20% | 873.374 SH | 08 Agosto 2026 | Giornaliero |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 32.329 NS | 30 Aprile 2026 | N-PORT |
| ESLG · Strategy Shares | 0,20% | 279 NS | 30 Aprile 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,19% | 6.824 NS | 30 Aprile 2026 | N-PORT |
| IMCB · iShares Trust | 0,19% | 24.582 SH | 08 Agosto 2026 | Giornaliero |
| ESUM · Strategy Shares | 0,19% | 2.146 NS | 30 Aprile 2026 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0,17% | 3.643 NS | 30 Aprile 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,16% | 155 NS | 31 Maggio 2026 | N-PORT |
| QYLD · Global X Funds | 0,16% | 98.226 NS | 30 Aprile 2026 | N-PORT |
| QCLR · Global X Funds | 0,15% | 45 NS | 30 Aprile 2026 | N-PORT |
| QYLG · Global X Funds | 0,15% | 1.572 NS | 30 Aprile 2026 | N-PORT |
| QTR · Global X Funds | 0,15% | 32 NS | 30 Aprile 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,15% | 24.910 NS | 31 Maggio 2026 | N-PORT |
| QRMI · Global X Funds | 0,15% | 174 NS | 30 Aprile 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,14% | 13.104 NS | 30 Aprile 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 2.485.842 SH | 08 Agosto 2026 | Giornaliero |